Artrita reactivă la un pacient după infecția COVID-19: raport de caz

Authors

Keywords:

artrita reactivă, infecţia COVID-19

Abstract

Infecția cu COVID-19 poate duce la o varietate mare de complicații care implică majoritatea sistemelor corpului, inclusiv pe cel musculo-scheletal. Una dintre manifestările clinice ale acesteia este artrita reactivă. În cele ce urmează prezentăm cazul clinic al unei femei de 56 de ani cu artrită reactivă post COVID-19 și monitorizarea acestuia.

References

1. Ahmed S, Padhan P, Misra R, Danda D. Update on poststreptococcal reactive arthritis: narrative review of a forgotten disease. Curr Rheumatol Rep. 2021;23:19. https://doi.org/10.1007/s11926-021-00982-3

2. Ahmed S, Zimba O, Gasparyan AY. COVID-19 and the clinical course of rheumatic manifestations. Clin Rheumatol. 2021; 40:2611-2619. https://doi.org/10.1007/s10067-021-05691-x

3. Angileri F, Legare S, Marino Gammazza A, Conway de Macario E, JL Macario A, Cappello F. Molecular mimicry may explain multi-organ damage in COVID-19. Autoimmun Rev. 2020; 19:102591. https://doi.org/10.1016/j.autrev.2020.102591

4. Antonio I-G, Jose FR, Rafael V, Eric LM. A brief history of Stoll-Brodie-Fiessinger-Leroy syndrome (Reiters syndrome) and reactive arthritis with a translation of Reiters original 1916 article into English. Curr Rheumatol Rev. 2004;1:71-79 https://doi.org/10.2174/1573397052954190

5. Baimukhamedov C, Barskova T, Matucci-Cerinic M. Arthritis after SARS-CoV-2 infection. Lancet Rheumatol. 2021; 3:e324-e325. https://doi.org/10.1016/S2665-9913(21)00067-9

6. Bekaryssova, D., Yessirkepov, M., Zimba, O., Gasparyan, A. Y., & Ahmed, S. (2022). Reactive arthritis before and after the onset of the COVID-19 pandemic. Clinical rheumatology, 1-12. Advance online publication. https://doi.org/10.1007/s10067-022-06120-3

7. Birra D, Benucci M, Landolfi L, et al. . COVID 19: a clue from innate immunity. Immunol Res 2020;68:161-8, https://doi.org/10.1007/s12026-020-09137-5

8. Bonelli M, Dalwigk K, Platzer A, et al. IRF1 is critical for the TNF-driven interferon response in rheumatoid fibroblast-like synoviocytes. Exp Mol Med. 2019; 51:1-11. https://doi.org/10.1038/s12276-019-0267-6

9. Cappello F. Is COVID-19 a proteiform disease inducing also molecular mimicry phenomena? Cell Stress Chaperones. 2020;25:381-382 https://doi.org/10.1007/s12192-020-01112-1

10. Carter JD, Hudson AP. Reactive arthritis: clinical aspects and medical management. Rheum Dis Clin North Am 2009;35:21-44 https://doi.org/10.1016/j.rdc.2009.03.010

11. Cincinelli G, Di Taranto R, Orsini F, et al. A case report of monoarthritis in a COVID-19 patient and literature review: simple actions for complex times. Medicine (Baltimore) 2021;100:e26089 https://doi.org/10.1097/MD.0000000000026089

12. Coath, F. L., Mackay, J., & Gaffney, J. K. (2021). Axial presentation of reactive arthritis secondary to COVID-19 infection. Rheumatology (Oxford, England), 60(7), e232-e233 https://doi.org/10.1093/rheumatology/keab009

13. Colmegna I, Cuchacovich R, Espinoza LR. HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations. Clin Microbiol Rev. 2004; 17:348-369. https://doi.org/10.1128/CMR.17.2.348-369.2004

14. Danssaert Z, Raum G, Hemtasilpa S.. Reactive arthritis in a 37-year-old female with SARS-CoV2 infection. Cureus 2020;12:e9698 https://doi.org/10.7759/cureus.9698

15. De Stefano L, Rossi S, Montecucco C, Bugatti S. Transient monoarthritis and psoriatic skin lesions following COVID-19. Ann Rheum Dis 2020; published on 4 Aug 2020.

16. Derksen VFAM, Kissel T, Lamers-Karnebeek FBG, et al (2021) Onset of rheumatoid arthritis after COVID-19: coincidence or connected? Ann Rheum Dis Annrheumdis 2021-219859. https://doi.org/10.1136/annrheumdis-2021-eular.1398

17. Di Carlo M, Tardella M, Salaffi F. Can SARS-CoV-2 induce reactive arthritis? Clin Exp Rheumatol. 2021;39(Suppl 128):25-26

18. Dotan A, Muller S, Kanduc D, et al. The SARS-CoV-2 as an instrumental trigger of autoimmunity. Autoimmun Rev. 2021; 20:102792. https://doi.org/10.1016/j.autrev.2021.102792

19. García-Kutzbach A, Chacón-Súchite J, García-Ferrer H, Iraheta I. Reactive arthritis: update 2018. Clin Rheumatol. 2018; 37:869-874. https://doi.org/10.1007/s10067-018-4022-5

20. Gasparotto M, Framba V, Piovella C, et al. Post-COVID-19 arthritis: a case report and literature review. Clin Rheumatol. 2021;40:3357-3362 https://doi.org/10.1007/s10067-020-05550-1

21. Hannu T, Inman R, Granfors K, Leirisalo-Repo M. Reactive arthritis or post-infectious arthritis? Best Pract Res Clin Rheumatol. 2006; 20:419-433. https://doi.org/10.1016/j.berh.2006.02.003

22. Hayes KM, Hayes RJP, Turk MA, Pope JE. Evolving patterns of reactive arthritis. Clin Rheumatol. 2019; 38:2083-2088. https://doi.org/10.1007/s10067-019-04522-4

23. Hønge BL, Hermansen M-LF, Storgaard M. Reactive arthritis after COVID-19. BMJ Case Rep. 2021;14:e241375 https://doi.org/10.1136/bcr-2020-241375

24. Houshmand H, Abounoori M, Ghaemi R, et al (2020) Ten-year-old boy with atypical COVID-19 symptom presentation: a case report. Clin Case Rep [Online ahead of print]. https://doi.org/10.22541/au.160066996.61637020/v2

25. Jali I. Reactive arthritis after COVID-19 infection. Cureus. 2020;12:e11761 https://doi.org/10.7759/cureus.11761

26. Liew IY, Mak TM, Cui L, et al. A case of reactive arthritis secondary to coronavirus disease 2019 infection. J Clin Rheumatol. 2020; 26:233. https://doi.org/10.1097/RHU.0000000000001560

27. López-Medina C, Molto A, Sieper J, et al. Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study. RMD Open. 2021; 7:e001450. https://doi.org/10.1136/rmdopen-2020-001450

28. Metyas S, Chen C, Aung T, Ballester A, Cheav S. Rheumatologic Manifestations of Post SARS-CoV-2 Infection: A Case Series. Curr Rheumatol Rev. 2022 Feb 11. Epub ahead of print. PMID: 35152867 https://doi.org/10.2174/1573397118666220211155716

29. Muyayalo KP, Huang DH, Zhao SJ, Xie T, Mor G, Liao AH. COVID-19 and Treg/Th17 imbalance: potential relationship to pregnancy outcomes. Am J Reprod Immunol 2020;84:e13304, https://doi.org/10.1111/aji.13304

30. Ono K, Kishimoto M, Shimasaki T, et al. Reactive arthritis after COVID-19 infection. RMD Open. 2020;6:e001350 https://doi.org/10.1136/rmdopen-2020-001350

31. Onofrio L, Caraglia M, Facchini G, Margherita V, De Placido S, Buonerba C. Toll-like receptors and COVID-19: a two-faced story with an exciting ending. Future Sci OA 2020;6:FSO605 https://doi.org/10.2144/fsoa-2020-0091

32. Pogreba-Brown K, Austhof E, Tang X, et al. Enteric pathogens and reactive arthritis: systematic review and meta-analyses of pathogen-associated reactive arthritis. Foodborne Pathog Dis. 2021;18:627-639 https://doi.org/10.1089/fpd.2020.2910

33. Poulas K, Farsalinos K, Zanidis C. Activation of TLR7 and innate immunity as an efficient method against COVID-19 pandemic: imiquimod as a potential therapy. Front Immunol 2020;11:1373. https://doi.org/10.3389/fimmu.2020.01373

34. Roongta R, Chattopadhyay A, Ghosh A (2021) Correspondence on "Onset of rheumatoid arthritis after COVID-19: coincidence or connected?" Ann Rheum Dis Annrheumdis 2021-220479.

35. Saricaoglu EM, Hasanoglu I, Guner R. The first reactive arthritis case associated with COVID-19. J Med Virol. 2021;93:192-193 https://doi.org/10.1002/jmv.26296

36. Schenker HM, Hagen M, Simon D, et al. Reactive arthritis and cutaneous vasculitis after SARS-CoV-2 infection. Rheumatology (Oxford) 2021;60:479-480 https://doi.org/10.1093/rheumatology/keaa689

37. Selmi C, Gershwin ME.. Diagnosis and classification of reactive arthritis. Autoimmun Rev 2014;13:546-9 https://doi.org/10.1016/j.autrev.2014.01.005

38. Sinaei R, Pezeshki S, Parvaresh S, et al. Post SARSCoV-2 infection reactive arthritis: a brief report of two pediatric cases. Pediatr Rheumatol Online J. 2021; 19:89. https://doi.org/10.1186/s12969-021-00555-9

39. Smatti MK, Cyprian FS, Nasrallah GK, et al. Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms. Viruses. 2019; 11:762. https://doi.org/10.3390/v11080762

40. Suhrbier A. Rheumatic manifestations of chikungunya: emerging concepts and interventions. Nat Rev Rheumatol. 2019; 15:597-611. doi: 10.1038/s41584-019-0276-9 https://doi.org/10.1038/s41584-019-0276-9

41. Taha SI, Samaan SF, Ibrahim RA, El-Sehsah EM, Youssef MK. Post-COVID-19 arthritis: is it hyperinflammation or autoimmunity? Eur Cytokine Netw. 2021 Dec 1;32(4):83-88. PMID: 35118946; PMCID: PMC8831681 https://doi.org/10.1684/ecn.2021.0471

42. Thomas KN, Anuja AK, Gupta L. Clinical profile of adults and children with reactive arthritis in India - A cohort study. Indian J Rheumatol. 2020; 15:304-309. https://doi.org/10.4103/injr.injr_126_20

43. Tuompo R, Lääveri T, Hannu T, et al. Reactive arthritis and other musculoskeletal symptoms associated with acquisition of diarrhoeagenic Escherichia coli (DEC) Ann Rheum Dis. 2020;79:605-611 https://doi.org/10.1136/annrheumdis-2019-216736

44. Wu D, Yang XO. TH17 responses in cytokine storm of COVID-19: an emerging target of JAK2 inhibitor Fedratinib. J Microbiol Immunol Infect 2020;53:368-70. https://doi.org/10.1016/j.jmii.2020.03.005

Published

2026-05-03

How to Cite

[1]
Sadovici-Bobeica, V. et al. 2026. Artrita reactivă la un pacient după infecția COVID-19: raport de caz. Public Health Economy and Management in Medicine. 2(93) (May 2026), 251–257.

Most read articles by the same author(s)

Similar Articles

1-10 of 120

You may also start an advanced similarity search for this article.